How pantothenol intervenes in Coenzyme-A biosynthesis of Mycobacterium tuberculosis
- PMID: 17679145
- DOI: 10.1016/j.bbrc.2007.07.080
How pantothenol intervenes in Coenzyme-A biosynthesis of Mycobacterium tuberculosis
Abstract
Coenzyme A is an indispensable cofactor for all organisms and holds a central position in a number of pathways. Prokaryotic enzymes involved in the synthesis of CoA are quite different from their mammalian counterparts; hence, they are good targets for the development of antimicrobials to treat many diseases. There are antimicrobials that act by inhibiting CoA biosynthesis. It has been suggested that pantothenol exhibits antibacterial activity by competitively inhibiting pantothenate kinase, a key regulatory enzyme for CoA synthesis. Contrary to these suggestions, in this paper, we demonstrate that pantothenol acts as a substrate for Mycobacterium tuberculosis and Escherichia coli pantothenate kinases. The product, 4'-phosphopantothenol, thus formed inhibits competitively the utilization of 4'-phosphopantothenate by CoaBC. Thus, it is the failure of CoaBC to utilize 4'-phosphopantothenol as a substrate that accounts for the bactericidal activity of pantothenol.
Similar articles
-
Coenzyme A biosynthesis: an antimicrobial drug target.FEMS Microbiol Rev. 2008 Jan;32(1):56-106. doi: 10.1111/j.1574-6976.2007.00093.x. FEMS Microbiol Rev. 2008. PMID: 18173393 Review.
-
Mycobacterium tuberculosis pantothenate kinase: possible changes in location of ligands during enzyme action.Acta Crystallogr D Biol Crystallogr. 2009 Apr;65(Pt 4):312-25. doi: 10.1107/S0907444909002170. Epub 2009 Mar 19. Acta Crystallogr D Biol Crystallogr. 2009. PMID: 19307712
-
Location and conformation of pantothenate and its derivatives in Mycobacterium tuberculosis pantothenate kinase: insights into enzyme action.Acta Crystallogr D Biol Crystallogr. 2011 Sep;67(Pt 9):774-83. doi: 10.1107/S0907444911024462. Epub 2011 Aug 9. Acta Crystallogr D Biol Crystallogr. 2011. PMID: 21904030
-
Coenzyme A: back in action.Prog Lipid Res. 2005 Mar-May;44(2-3):125-53. doi: 10.1016/j.plipres.2005.04.001. Epub 2005 Apr 20. Prog Lipid Res. 2005. PMID: 15893380 Review.
-
Structural and biochemical characterization of compounds inhibiting Mycobacterium tuberculosis pantothenate kinase.J Biol Chem. 2013 Jun 21;288(25):18260-70. doi: 10.1074/jbc.M113.476473. Epub 2013 May 9. J Biol Chem. 2013. PMID: 23661699 Free PMC article.
Cited by
-
Identification of specific metabolites in culture supernatant of Mycobacterium tuberculosis using metabolomics: exploration of potential biomarkers.Emerg Microbes Infect. 2015 Jan;4(1):e6. doi: 10.1038/emi.2015.6. Epub 2015 Jan 28. Emerg Microbes Infect. 2015. PMID: 26038762 Free PMC article.
-
A putative terpene cyclase gene (CcPtc1) is required for fungal development and virulence in Cytospora chrysosperma.Front Microbiol. 2023 Feb 20;14:1084828. doi: 10.3389/fmicb.2023.1084828. eCollection 2023. Front Microbiol. 2023. PMID: 36891381 Free PMC article.
-
Metabolic Activation versus Masked Prodrugs: Bisubstrate Mimic Inhibitors of CoaBC's PPCS Activity in Mycobacterium tuberculosis and Staphylococcus aureus.ACS Infect Dis. 2025 Jun 13;11(6):1508-1517. doi: 10.1021/acsinfecdis.5c00047. Epub 2025 Jun 3. ACS Infect Dis. 2025. PMID: 40459851 Free PMC article.
-
Antimicrobial activity of pantothenol against staphylococci possessing a prokaryotic type II pantothenate kinase.Microbes Environ. 2014;29(2):224-6. doi: 10.1264/jsme2.me13178. Epub 2014 Apr 22. Microbes Environ. 2014. PMID: 24759689 Free PMC article.
-
Pantothenate and CoA biosynthesis in Apicomplexa and their promise as antiparasitic drug targets.PLoS Pathog. 2021 Dec 30;17(12):e1010124. doi: 10.1371/journal.ppat.1010124. eCollection 2021 Dec. PLoS Pathog. 2021. PMID: 34969059 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases